Enanta Pharmaceuticals (ENTA) Profit After Tax Growth (5y) (2017 - 2026)
Enanta Pharmaceuticals (ENTA) Profit After Tax Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.90% |
| Dec 31, 2025 | -7.47% |
| Sep 30, 2025 | 8.62% |
| Jun 30, 2025 | -5.06% |
| Mar 31, 2025 | -30.40% |
| Dec 31, 2024 | -29.61% |
| Sep 30, 2024 | -38.72% |
| Jun 30, 2024 | -39.17% |
| Mar 31, 2024 | -56.93% |
| Dec 31, 2023 | -26.85% |
| Sep 30, 2023 | -24.78% |
| Jun 30, 2023 | -31.46% |
| Mar 31, 2023 | -37.97% |
| Dec 31, 2022 | -34.97% |
| Sep 30, 2022 | -22.17% |
| Jun 30, 2022 | -30.34% |
| Mar 31, 2022 | -44.18% |
| Dec 31, 2021 | -43.32% |
| Sep 30, 2021 | -68.67% |
| Jun 30, 2021 | -86.11% |